Scientific Publication
The ASMQ - FDC
Abstract
This presentation describes the new fixed-dose antimalarial formulation ASMQ (artesunate + mefloquine) and its advantages in terms of ease of use, efficacy and tolerability (as well as contraindications); reasons why it needs further study in Africa are given